Metabolic Dynamics During Physical Activity
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03485716 |
|
Recruitment Status :
Completed
First Posted : April 2, 2018
Last Update Posted : April 2, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Healthy Men and Women | Other: running on a treadmill under normoxia or hypoxia | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 34 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Basic Science |
| Official Title: | Metabolic Dynamics During Physical Activity Under Normobaric Normoxia or Moderate Hypoxia - a Pilot Study |
| Actual Study Start Date : | August 1, 2016 |
| Actual Primary Completion Date : | March 31, 2017 |
| Actual Study Completion Date : | December 31, 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: running under hypoxia - first
running under hypoxia (first day) and normoxia (second day)
|
Other: running on a treadmill under normoxia or hypoxia
|
|
Active Comparator: running under normoxia - first
running under normoxia (first day) and hypoxia (second day)
|
Other: running on a treadmill under normoxia or hypoxia
|
- Change in capillary lactate/pyruvate Ratio (dimension-free) [ Time Frame: t = 0 min (before exercise); t = 10, 20 and 30 min during exercise; t = 50 and 60 min during recovery ]marker for the ratio between anaerobic / aerobic glycolysis
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- healthy volunteers
- written informed consent
Exclusion Criteria:
- known cardio-vascular, lung, metabolic, endocrine, hematologic, kidney or neurologic diseases
- pregnancy, lactating period
- unability to understand study content and aims and to give written informed consent
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03485716
| Germany | |
| Charite University Medicine, ECRC | |
| Berlin, Germany, 13125 | |
| Principal Investigator: | Michael Boschmann, Dr. | Charite University, Berlin, Germany |
| Responsible Party: | Michael Boschmann, Dr. Michael Boschmann, Charite University, Berlin, Germany |
| ClinicalTrials.gov Identifier: | NCT03485716 |
| Other Study ID Numbers: |
Hypoxitrain 2 |
| First Posted: | April 2, 2018 Key Record Dates |
| Last Update Posted: | April 2, 2018 |
| Last Verified: | March 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
metabolism metabolome physical activity hypoxia |

